Drug Dose

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Drug Dose trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 50 trials

RecruitingPhase 1/2

NCT07181161

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer agents for treatm…

United States177 participantsStarted 2025-10-01

Treatment: AZD0516, AZD9574

RecruitingPhase 1/2

NCT07436728

A Study of TAK-505 in Adults With Solid Tumors

Solid tumors occur when cells in an organ or tissue (for example in the lung or liver) start growing out of control (cancer) and form a lump or mass of cells. T…

United States151 participantsStarted 2026-05-11

Treatment: TAK-505

RecruitingPhase 1

NCT07318805

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

The purpose of this study is to learn about the safety and effects of the study medicine when given alone or together with other anti-cancer therapies. Anti-can…

United States260 participantsStarted 2025-12-23

Treatment: PF-08032562, Fulvestrant

RecruitingPhase 2

NCT06233461

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to…

Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. The purpose of this study is to evaluate the efficacy…

United States268 participantsStarted 2024-03-05

Treatment: TAK-279, Placebo

RecruitingPhase 1

NCT05872295

IKS014 in Advanced Solid Tumors That Express HER2

This study will evaluate the recommended dose for further clinical development, safety, tolerability, anti-tumor activity, immunogenicity, pharmacokinetics and…

United States, Australia165 participantsStarted 2023-09-14

Treatment: IKS014

RecruitingPhase 1/2

NCT06618287

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult…

The purpose of this study is to evaluate the safety, tolerability, drug levels, and preliminary efficacy of BMS-986507 combinations in adult participants with a…

United States416 participantsStarted 2025-02-04

Treatment: BMS-986507, Osimertinib

All recent trials (100 shown)

Active — Not RecruitingPhase 1

NCT04401020

First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL

Primary Objective: To determine the maximum tolerated dose (MTD) of SAR442257 administered as a single agent in patients with relapsed and refractory multiple…

United States, Czechia47 participantsStarted 2020-07-24

Treatment: SAR442257

Not Yet RecruitingPhase 1/2

NCT07529808

Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma

This study is looking at how safe BHB810 is in adults with gastric and gastroesophageal adenocarcinoma (GEJ). The purpose of this study is also to look at: how…

Location not specified164 participantsStarted 2026-06

Treatment: BHB810

Drug Dose

Trial phase breakdown

Trial status

Actively recruiting — 50 trials

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

A Study of TAK-505 in Adults With Solid Tumors

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to…

IKS014 in Advanced Solid Tumors That Express HER2

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult…

All recent trials (100 shown)

First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL

Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma

Trial phase breakdown

Trial status

Actively recruiting — 50 trials

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

A Study of TAK-505 in Adults With Solid Tumors

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to…

IKS014 in Advanced Solid Tumors That Express HER2

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult…

All recent trials (100 shown)

First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL

Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma

A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and…

Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of TAK- 063 in Participants With Stable Schizoph…

Effects of TAK-063 on Preventing Ketamine-Induced Brain Activity Changes as Well as Psychotic-Like Symptoms in Healthy M…

A Study to Learn if a Medicine Called Itraconazole Changes How the Body Processes the Study Medicine PF-08642534 in Heal…

A Study to Learn How a Single Dose of the Study Medicine Called PF-08057418 is Tolerated in the Body of Healthy Adults.

An [^11C]T-773 Positron Emission Tomography (PET) Study to Determine Phosphodiesterase10A Occupancy by TAK-063

ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer

A Study of ZW191 in Participants With Solid Tumors

A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity

Study to Assess the Pharmacokinetic Bioequivalence of Budesonide and Albuterol With an Alternate Propellant Compared to…

DPX-Survivac and Checkpoint Inhibitor in DLBCL

A Study to Learn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Given Togethe…

PF-07104091 as a Single Agent and in Combination Therapy

Clinical Application of Simcyp-Guided Warfarin Initiation Doses in Cirrhotic Patients With Portal Vein Thrombosis

A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arteri…

A Study on the Effects in Healthy People of a New Drug Called PDI204 for Treating COVID-19

A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity

First in Human Study of M6223